TABLE 1.
Treatment during: | Essential oil component added | Concn of essential oil component (mM) | Motility classification
|
||
---|---|---|---|---|---|
Motile | Reduced motility | Nonmotile | |||
Overnight incubation | Control | 0 | X | ||
Carvacrol | 1 | X | |||
p-Cymene | 1 | X | |||
10 | X | ||||
Mid-exponential growth phase | Control | 0 | X | ||
Carvacrol | 0.3 | X | |||
0.5 | X | ||||
0.8 | X | ||||
1.0 | X | ||||
p-Cymene | 0.3 | X | |||
0.5 | X | ||||
0.8 | X |
Cells were grown overnight in MHB in the presence of the substance or were treated in the exponential growth phase.